Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations

Matthew C Evans1, Josephine Barnes, Casper Nielsen

  • 1Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.

European Radiology
|September 18, 2009
PubMed
Abstract

Insights

Brain atrophy and ventricular enlargement measured by MRI correlate with cognitive decline in Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients, serving as key biomarkers.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomarkers

Background:

  • Alzheimer's disease (AD) and mild cognitive impairment (MCI) are characterized by neurodegeneration.
  • Quantifying brain changes and cognitive decline is crucial for understanding disease progression.

Purpose of the Study:

  • To investigate the association between MRI-derived volumetric changes (whole-brain and ventricular) and cognitive score changes.
  • To evaluate these associations across control, MCI, and AD subject groups.

Main Methods:

  • Utilized T1-weighted volumetric MRIs from 131 control, 231 MCI, and 99 AD subjects (Alzheimer's Disease Neuroimaging Initiative cohort).
  • Assessed changes in whole-brain and ventricular volumes over 12 months.
  • Calculated changes in cognitive scores: Mini-Mental State Examination (MMSE), Alzheimer's Disease Assessment Scale-Cognitive (ADAS-cog), and Trails Test.

Main Results:

  • Significant differences in brain atrophy and ventricular enlargement rates were observed between subject groups (p < 0.0005).
  • In MCI and AD groups, atrophy and ventricular expansion correlated with MMSE changes.
  • MCI subjects progressing to AD showed higher atrophy and ventricular expansion rates compared to stable MCI subjects.

Conclusions:

  • Whole-brain atrophy and ventricular enlargement rates differ significantly across control, MCI, and AD groups.
  • These volumetric changes serve as relevant biomarkers for tracking disease progression and cognitive decline in AD and MCI.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...